Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

Study Overview
=================
Brief Summary
-----------------
Oral mucositis is one of the most spread side effects of anticancer therapy. It is associated with both chemo- and radiotherapy, decreases QoL, relative dose intensity and leads to nutritive deficiency. Oral mucositis causes secondary infections, increased hospital stay, whereas pain syndrome results in an emotional distress, anorexia and disables natural feeding.

Detailed Description
-----------------
Primary: To evaluate the efficacy of ONCOXIN on oral mucositis symptoms in patients who receive chemotherapy and/or radiotherapy. Secondary: To evaluate the effects of ONCOXIN on nutritional status in patients who receive chemotherapy and/or radiotherapy.

Official Title
-----------------
Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients. Real World Setting Study.

Conditions
-----------------
Mucositis Oral

Intervention / Treatment
-----------------
* Dietary Supplement: Oncoxin®


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: A signed and dated informed consent form; Patients of both genders, aged 45-75; Malignant neoplasms which have radio-, chemotherapy or their combinations prescribed; ECOG ≤3; WHO oral toxicity scale grade 2 - 3. Exclusion Criteria: Significant, according to the investigator judgement, concomitant diseases or states which make it complicate or even impossible the patient's participation in the study or make it difficult to interpret the clinical data obtained in any stage of the study always including the following: Mental disorders; Serious/chronic infectious and parasitic diseases; Intolerability to any of ONCOXIN components. Relations with study center personnel (study center staff or family member of the investigator, coordinator or assistant). If the patient fails to assess his/her physical and emotional condition; If the patient fails to comply with the requirements; Patient's refusal to participate in the study; Pregnancy or lactation.

Ages Eligible for Study
-----------------
Minimum Age: 45 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Oncoxin®<br>Chemo-, radiotherapy or their combination + standard oral mucositis treatment + ONCOXIN | Dietary Supplement: Oncoxin®<br>* Chemo-, radiotherapy or their combination + standard oral mucositis treatment + ONCOXIN 25 ml twice daily for 20 days;<br>|
| No Intervention: No Oncoxin Treatment®<br>Chemo-, radiotherapy or their combination + standard oral mucositis treatment. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Oral mucositis grade in patients during chemotherapy and radiotherapy treatments | Efficacy of OCOXIN on oral mucositis symptoms in patients who receive chemotherapy and/or radiotherapy with WHO oral toxicity scale grades. The WHO scale is dependent on both objective and subjective variables, and measures anatomical, symptomatic as well as functional components of oral mucositis. WHO Oral Mucositis Grading Scale: 0 (none): None I (mild): Oral soreness, erythema II (moderate): Oral erythema, ulcers, solid diet tolerated III (severe): Oral ulcers, liquid diet only IV (life-threatening): Oral alimentation impossible | 21 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Nutritional status of the patients during Chemotherapy and radiotherapy treatments related with weight gain | Effects of ONCOXIN on nutritional status in patients who receive chemotherapy and/or radiotherapy measured with body mass measures. | 21 days | 
| Nutritional status of the patients during Chemotherapy and radiotherapy treatments | Effects of ONCOXIN on nutritional status in patients who receive chemotherapy and/or radiotherapy measured with days with the intake of regular food. | 21 days | 
| Nutritional status of the patients during Chemotherapy and radiotherapy treatments | Effects of ONCOXIN on nutritional status in patients who receive chemotherapy and/or radiotherapy measured with days with no loss of appetite complaints. | 21 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Oral Mucositis, Nutritional supplement, Chemotherapy, Radiotherapy, Ocoxin / Oncoxin